image: The ESCEO-IOF Young Investigator Awards 2024 were awarded to 20 young researchers from 16 countries. The prestigious Awards were presented on April 14th at the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2024), in recognition of outstanding research abstracts presented at the Congress.
Credit: IOF
The International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) have presented ESCEO-IOF Young Investigator Awards to 20 young investigators from 16 countries.
The prestigious Awards were presented on April 14th, 2024 at the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2024), in recognition of the young investigators’ outstanding research abstracts presented at the Congress.
IOF President Professor Nicholas Harvey stated:
“On behalf of the IOF and ESCEO, I extend heartfelt congratulations to the young investigators for their accomplishments and offer my best wishes for ongoing success in their research and further career development.”
The winning investigators are:
- Alain Sherman (United States)
- Nitchanant Kitcharanant (Thailand)
- Brenda Lenardt (Brazil)
- Sigrid Janssens (Belgium)
- Griselda-Adriana Cruz-Priego (Mexico)
- Bedru Abafita (Ethiopia)
- Fanny Buckinx (Belgium)
- Fiona Kirkham-Wilson (United Kingdom)
- Lieke Maas (Netherlands)
- Stefania D'Angelo (United Kingdom)
- Radnaa Enkhdelger (Mongolia)
- Judith Everts-Graber (Switzerland)
- Céline Demonceau (Belgium)
- Alireza Azarboo (Iran)
- Tafadzwa Madanhire (Zimbabwe)
- Hannah Wilson (United Kingdom)
- Rutika Thakur (India)
- Ben Ayed Hiba (Tunisia)
- Gaia Palmini (Italy)
- Enisa Shevroja (Albania)
###
About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO)
Held jointly by IOF and ESCEO, the WCO-IOF-ESCEO annual congress is the world’s largest forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including osteoporosis, osteoarthritis, sarcopenia, and frailty. The WCO-IOF-ESCEO 2024 is being held from April 11-14, 2024 in London, UK. For complete information visit www.wco-iof-esceo.org/
The next WCO-IOF-ESCO is planned from April 10-13, 2025 in Rome, Italy.
About ESCEO
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policymakers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. www.esceo.org/
About IOF
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as more than 330 patient, medical and research organizations, work together to make fracture prevention and healthy mobility a worldwide healthcare priority. www.osteoporosis.foundation @iofbonehealth